tiprankstipranks
HLS Therapeutics Inc (TSE:HLS)
TSX:HLS
Canadian Market
HLS
HLS Therapeutics Inc
RESEARCH TOOLSreports

HLS Therapeutics Inc (HLS) Income Statement

45 Followers

HLS Therapeutics Inc Income Statement

Last quarter (Q4 2025), HLS Therapeutics Inc's total revenue was $15.43M, a decrease of -0.73% from the same quarter last year. In Q4, HLS Therapeutics Inc's net income was $-1.36M. See HLS Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 56.47M$ 56.62M$ 63.07M$ 61.47M$ 60.01M
Gross Profit
$ 24.01M$ 47.62M$ 55.45M$ 56.49M$ 56.04M
Operating Expenses
$ 28.19M$ 55.31M$ 55.45M$ 69.98M$ 62.32M
Depreciation and Amortization
$ 22.20M$ 22.72M$ 31.94M$ 34.40M$ 30.26M
EBITDA
$ 18.02M$ 17.22M$ 12.88M$ 18.00M$ 25.41M
Operating Income
-$ -7.69M$ -10.35M$ -13.44M$ -6.24M
Other Income/Expenses
$ -8.92M$ -7.90M$ -17.45M$ -10.22M$ -5.52M
Pretax Income
$ -13.10M$ -15.58M$ -27.80M$ -23.72M$ -11.81M
Net Income
$ -12.65M$ -19.66M$ -27.53M$ -23.60M$ -13.12M
Per Share Metrics
Basic EPS
$ -0.40$ -0.62$ -0.85$ -0.73$ -0.41
Diluted EPS
$ -0.40$ -0.62$ -0.85$ -0.73$ -0.41
Weighted Average Shares Outstanding
 31.53M 31.84M 32.26M 32.33M 32.18M
Weighted Average Shares Outstanding (Diluted)
 31.53M 31.84M 32.26M 32.43M 32.18M
Currency in USD

HLS Therapeutics Inc Earnings and Revenue History